Westleaf’s Exclusive Partnership with Xabis: Prepared for the Next Phase of the Cannabis Industry


Joy Crosby

June 10th, 2019

App, Exclusive, News, Top News


As a relatively new market, the cannabis industry in Canada is seeing tremendous growth amongst its leading companies. Westleaf Inc. (TSX-V: WL), a cannabis company headquartered in Calgary, Alberta, has firmly established itself as a serious contender in this market. Its focus on high-quality cannabis production, customer focused brands and an innovative retail experience has marked them as one of Canada’s most intriguing companies.

In a move to further advance its position within the cannabis industry, Westleaf has announced that its subsidiary, Westleaf Labs LP, has entered into a definitive agreement with Xabis Inc.

Xabis is a turnkey processing partner, that combines scientific discipline and business expertise. The company is wholly focussed on the plant-to-product portion of the industry. Under this new agreement, Xabis will provide Westleaf Labs with exclusive access to its extraction, processing, manufacturing and product development expertise within the Canadian market.

Click here to see the company’s corporate presentation.

Industry Leading Expertise

Xabis is a company led by a diverse team of industry experts. From engineers, accountants, lawyers, marketing, branding and operational experts, plus some of the industry’s leading chemical, biological, atmospheric and environmental PhDs, in total, Xabis offers over 150 years of combined experience.

Dale Zink is the CEO of Xabis, and has over 25 years experience in finance, business and IT. He leads a group of PhDs with wide-ranging experience in biotechnology and chemical engineering, which includes extensive experience in the extraction and pharmaceutical industries.

Although this exclusive relationship marks Xabis’s first time working within the Canadian market, the company is well versed in this industry. Xabis has designed, built and operated facilities in nine US states in which cannabis is either medically or recreationally legal, and has developed over 200 cannabis derivative products.

Room for Growth

Operations will take place in Westleaf’s Calgary-based extraction, processing and manufacturing facility, The Plant. The Plant is a 60,000 square foot complex. Its 15,000 sq. ft Phase 1 section will allow for research and development, processing, extraction, manufacturing and order fulfilment and have the capacity to process 65,000 kgs of cannabis per year. Phase 1 is currently under construction, and due for completion this month.

“In terms of scalability, The Plant currently occupies a quarter of its space, and retains an additional 45,000 square feet which is available for expansion”

Furthermore, Health Canada prepares for amendments to be made to cannabis legislation, currently predicted to be finalised later this year, and these amendments will legalise the production and sale of edible cannabis products. This will give The Plant the freedom to produce a new line of derivative and consumable products, including oils, gels, capsules, vape pens, topicals and edibles. As the value of cannabis is much higher once it has been processed into other products, this will allow Westleaf to capitalize on this lucrative business opportunity. It will also cater to the huge, predicted shift in consumer demand from flower to alternative cannabis products, once they have been legalised.

Preparations to go Global

Located in Calgary, The Plant is strategically located in the largest retail market in the prairies and also has easy access to national transportation systems, which allows for sales to other markets across Canada.

As a forward-looking company, Westleaf and Xabis are intentionally building The Plant to meet EU GMP specifications, to ensure compliance for international export capabilities, and allow the option to sell globally as new cannabis markets open up around the world.

Click here to see the company’s corporate presentation.

Under the Westleaf brand portfolio, The Plant is designed to produce a diverse collection of cannabis derivative products. In addition to this, Westleaf plans to offer white labelling services, in which they will produce completed products for third parties to sell as their own. They will also offer contract manufacturing services for distillation and raw extract.

Intelligent Alliance

The agreement between Westleaf and Xabis could potentially accelerate Westleaf’s position in the cannabis industry. Securing this exclusive relationship with Xabis in the Canadian market will give Westleaf an edge and an early advantage in the upcoming changes in legislation. As a dynamic and ambitious company, Westleaf looks set to continue to impress both customers and shareholders as a leader in this new phase of the cannabis market. For more information about Westleaf and its operations visit: https://www.westleaf.com/wp-content/uploads/2019.06-Westleaf_Inc.-Investor_Presentation.pdf

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Joy Crosby



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading